Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of cognitive impairment, with a notably ...

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

More than 20 respiratory conditions could receive extra financial support from PIP to help with daily living costs ...

Fluticasone (brand name Flovent) is a prescription corticosteroid used to prevent breathing difficulties, chest tightness, wheezing and coughing caused by respiratory disorders such as COPD. It works ...

Cardiopulmonary assessment tool detects and monitors digital biomarkers to support health management and help improve ...

COPD is the term given to a group of lung conditions that cause breathing problems ... despite four of the top six causes of ...

GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval of a new indication for Nucala ...

The list includes a number of common respiratory health conditions such as asthma, pneumonia, sleep apnoea and chronic ...

A review of the management of COPD is presented, with particular emphasis on the effect on the approach to management of new information which has become available in the 5 years since the BTS ...

U.K. researchers at Nottingham Trent University, the University of Southampton and University Hospital Southampton and ...

The global tracheal tubes and airway products market is expected to grow from USD 2,242.2 million in 2023 to USD 3,890.3 ...